81376-54-7

Basic information

• Product Name: 4-(2-METHYL-1H-IMIDAZOL-1-YL)PHENOL
• Synonyms: 4-(2-METHYL-1H-IMIDAZOL-1-YL)PHENOL
• CAS NO: 81376-54-7
• Molecular Formula: C₁₀H₁₀N₂O
• Molecular Weight: 174.1992
• Mol File: 81376-54-7.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 373.8 °C at 760 mmHg
• Flash Point: 179.9 °C
• Appearance: /
• Density: 1.17 g/cm³
• CAS DataBase Reference: 4-(2-METHYL-1H-IMIDAZOL-1-YL)PHENOL(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2-METHYL-1H-IMIDAZOL-1-YL)PHENOL(81376-54-7)
• EPA Substance Registry System: 4-(2-METHYL-1H-IMIDAZOL-1-YL)PHENOL(81376-54-7)

Safety Data

• Hazardous Substances Data: 81376-54-7(Hazardous Substances Data)

Usage

General Description

4-(2-Methyl-1H-imidazol-1-yl)phenol is a chemical compound that consists of a phenolic ring with a 2-methyl-1H-imidazol-1-yl substituent attached to it. It is commonly used in the pharmaceutical industry, particularly as an intermediate in the synthesis of pharmaceutical drugs. 4-(2-METHYL-1H-IMIDAZOL-1-YL)PHENOL has also demonstrated antimicrobial and antioxidant activity, making it potentially useful in the development of new drugs and industrial applications. Additionally, it has been studied for its potential role in the treatment of inflammation and cancer. Overall, 4-(2-Methyl-1H-imidazol-1-yl)phenol has diverse and promising applications in the fields of medicine, chemistry, and industry.

Upstream product

• 68337-08-6 1-(4-methoxyphenyl)-2-methyl-1H-imidazole 
• 696-62-8 para-iodoanisole 
• 104-92-7 1-bromo-4-methoxy-benzene 
• 693-98-1 2-methylimidazole 
• 5720-07-0 4-methoxyphenylboronic acid 
• 78009-26-4 1-(3,5-di-t-butyl-4-hydroxyphenyl)-2-methylimidazole 

Downstream Products

• 1430210-67-5 5-(2-(3,4-dimethoxyphenyl)propan-2-yl)-1-(4-fluorophenyl)-2-((2-(4-(2-methyl-1H-imidazol-1-yl)phenoxy)ethyl)thio)-1H-imidazole 
• 137208-87-8 2-[4-(2-Methyl-1H-imidazol-1-yl)phenoxy]ethanol 

Relevant articles and documents

HETEROCYCLIC COMPOUND

The present invention provides a compound having a PDE2A selective inhibitory action, which is useful as an agent for the prophylaxis or treatment of schizophrenia, Alzheimer's disease and the like. The present invention is a compound represented by the f

Compounds having one or more aminosulfaonyloxy radicals useful as pharmaceuticals

Methods of treating chronic arthritis and osteoporosis which utilize both known and novel compounds which would fall under the general formula:(HO)p--A--[--OS(O) 2 NR 1 R 2 ] zwherein A encompasses a wide range of values including but not limited to aryl, loweralkyl, cycloalkyl, and carbohydrates including sucrose and fructose; p is equal to the number of unreacted hydroxy groups contained on the molecule and may be zero; z is the number of --OS(O) 2 NR 1 R 2 groups and is always at least one; R 1 and R 2 are selected from hydrogen, loweralkyl, carboxy and the like; a novel process for preparing the compounds is provided wherein an appropriate sulfamic acid aryl ester is reacted with a hydroxy substituted A radical which may or may not contain thereon protected carboxyl, amino or hydroxy substituents, in an aprotic solvent containing a tertiary amine base. Pharmaceutical compositions for the treatment of chronic arthritis and osteoporosis are also provided.